The immune microenvironment landscape was found to be poor for both GEP NET G3 and GEP NECs, with a slight enrichment of CD4 and CD8 T cells in GEP-NECs and of cancer-associated fibroblasts and macrophages (M2-like) in GEP-NET G3. This evidence concerns the gene CD8A and cancer.